Showing results (171-180 of 243) with videos related to
Sort By:
Pageof 25
Cancer Chemotherapy and Pharmacology|November 27, 2012
Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusionKazuhiro Kitamura, Kaoru Kubota, Masahiro Ando, et al.Cancer Treatment and Research Communications|November 29, 2020
Association between continuous decrease of plasma VEGF-A levels and the efficacy of chemotherapy in combination with anti-programmed cell death 1 antibody in non-small cell lung cancer patientsTakehiro Tozuka, Noriko Yanagitani, Hiroaki Sakamoto, et al.Respiratory Investigation|May 15, 2026
Pulmonary vascular resistance is associated with two-year clinical outcomes in non-hypoxemic COPD with mild pulmonary hemodynamic abnormalitiesShun Idei, Yosuke Tanaka, Fushi Dong, et al.Journal for Immunotherapy of Cancer|March 1, 2019
Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case reportTeppei Sugano, Masahiro Seike, Yoko Funasaka, et al.Investigational New Drugs|April 14, 2023
Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patientsTakehiro Tozuka, Noriko Yanagitani, Hiroshi Yoshida, et al.Oncotargets and Therapy|June 29, 2023
Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case ReportHirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|May 21, 2025
Phase II Study of Short Hydration without Diuretics for Cisplatin-Based ChemotherapyTetsuya Wako, Ryosuke Arakawa, Shinji Nakamichi, et al.Translational Lung Cancer Research|April 15, 2026
Prognostic impact of thyroid transcription factor-1 expression and the efficacy of carboplatin plus (nab-) paclitaxel in non-squamous non-small cell lung cancer complicated with idiopathic interstitial pneumoniasYuto Terashima, Aya Fukuizumi, Koichiro Kamio, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|January 17, 2024
Clinicopathological Characteristics of Everolimus-Associated Interstitial Lung Disease: A Single-Center Consecutive AnalysisYoshinobu Saito, Yasuhiro Terasaki, Takeru Kashiwada, et al.Japanese Journal of Clinical Oncology|September 19, 2024
A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancersSusumu Takeuchi, Akinobu Yoshimura, Atsushi Sofuni, et al.Pageof 25